Pazel G Jackson Jr bought $15k of CARV
director at CARVER BANCORP INC. 8,982 shares at an average of $1.67, traded Nov 25, 2024, filed Nov 27, 2024.
Score components
- +15RoleDirector
- 0Trade size$15k at market
- +10Relative to holdingsHoldings up 142%
- 0Price contextNo price history yet
- +15Cluster5 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-24-036324, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | POpen-market purchase Common Stock | +8,982 | $1.67 | $15k | 15,308 | Nov 27, 2024 |
Related signals
Other insiders at CARVER BANCORP INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 54Moderate | CARVER BANCORP INC | Donald Felix President and CEO | $45k 26,946 shares | - | |
| 40Moderate | CARVER BANCORP INC | Colvin Grannum director | $20k 11,976 shares | +688% | |
| 50Moderate | CARVER BANCORP INC | Craig C MacKay director | $100k 59,880 shares | +1198% | |
| 40Moderate | CARVER BANCORP INC | Kenneth Knuckles director | $15k 8,982 shares | +898% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.